AbbVie is pharma’s first birth of the new year

By Tracy Staton One of the biggest deals of the year is already done. Abbott Laboratories’ ($ABT) pharmaceuticals business was reborn as an independent company on New Year’s ...

Device tax survives New Year’s as industry vows to keep fighting

By Damian Garde January feels about 2.3% colder for the medical device industry, as the excise tax on U.S. sales survived through its first-of-the-year date of birth and efforts ...

Zoll sues Philips over patient monitoring tech patent

By Mark Hollmer Zoll and Philips closed out 2012 butting heads over a patient monitoring equipment patent, and a federal court in the U.S. is going to have to settle the matter. Zoll ...

FDA confronts Mindray over patient monitor quality control

By Mark Hollmer Mindray ($MR) is in trouble with the FDA over manufacturing problems with the company’s patient monitors and other medical equipment. Regulators cited China’s ...

Quest Diagnostics slims down for the new year

By Mark Hollmer Quest Diagnostics’ ($DGX) ongoing restructuring efforts took a new twist this week. The company disclosed on the last day of 2012 that it had sold most of its ...

Dune wins FDA approval for MarginProbe

By Damian Garde Dune Medical Devices‘ headline-grabbing cancer tool has capped its rapid road through the FDA with a full pre-market approval, getting the agency’s sign-off ...

Zimmer recall gets FDA’s highest-risk Class I status | MassDevice.com On Call

By MassDevice staff The FDA slaps Zimmer with Class I status for a global medical device recall of spinal surgery instruments.  MASSDEVICE ON CALL — The FDA slapped medical device ...

FDA tracking proposal could require packaging line changes

Medical device makers would need to use automatic identification and data capture technology for marking implantable and all devices and their packaging. By Stephen Barlas  The U.S. ...

Kinnikinnick Foods recalls own brand Pie Crusts in Canada

By FBR Staff Writer Canada-based Kinnikinnick Foods is voluntarily recalling its own brand Pie Crusts as the product contains egg that is not mentioned on the labeling, according to ...

Biggest Biotech Trends of 2012

GEN takes a look back at some key biopharma developments of the past 12 months. The world didn’t come to an end in 2012, but the biopharma world ended the year holding its breath, ...

What The Fiscal Cliff Could Mean For The FDA

By Matthew Herper A lot of the discussion over the last-minute effort to come to a deal over the fiscal cliff have focused on whether congress and President Obama can stave off the ...

US FDA grants ANDA for Breckenridge’s rizatriptan benzoate tablets

By PBR Staff Writer The US FDA has approved Abbreviated New Drug Application (ANDA) for Breckenridge Pharmaceutical’s rizatriptan benzoate tablets. Following the ANDA approval, ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS